Targeting the Hippo pathway in cancers via ubiquitination dependent TEAD degradation
Trang H. Pham, Anwesha Dey(Unknown)
Cited by 1
Related Papers
An allosteric pan-TEAD inhibitor blocks oncogenic YAP/TAZ signaling and overcomes KRAS G12C inhibitor resistance
|Nature Cancer|2023|188
R-Roscovitine simultaneously targets both the p53 and NF-κB pathways and causes potentiation of apoptosis: implications in cancer therapy
|Cell Death and Differentiation|2007|73